Patents by Inventor Claus-Juergen Koelln

Claus-Juergen Koelln has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR THE MANUFACTURE AND USE OF PANCREATIN MICROPELLET CORES
    Publication number: 20240148660
    Abstract: A process for manufacturing and using pancreatin micropellet cores and pancreatin micropellets which are substantially free of synthetic oils. In one embodiment, a pharmaceutical composition is provided comprising a pancreatin micropellet with the enteric coating being designed to deliver pancreatin to the upper portion of the intestine of a mammal for release.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 9, 2024
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Guido Ruesing
  • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
    Publication number: 20240131125
    Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
    Type: Application
    Filed: June 19, 2023
    Publication date: April 25, 2024
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Andreas Koerner
  • PROCESS FOR THE MANUFACTURE AND USE OF PANCREATIN MICROPELLET CORES
    Publication number: 20220183988
    Abstract: A process for manufacturing and using pancreatin micropellet cores and pancreatin micropellets which are substantially free of synthetic oils. In one embodiment, a pharmaceutical composition is provided comprising a pancreatin micropellet with the enteric coating being designed to deliver pancreatin to the upper portion of the intestine of a mammal for release.
    Type: Application
    Filed: March 4, 2022
    Publication date: June 16, 2022
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Guido Ruesing
  • Process for the manufacture and use of pancreatin micropellet cores
    Patent number: 11266607
    Abstract: A process for manufacturing and using pancreatin micropellet cores and pancreatin micropellets which are substantially free of synthetic oils. In one embodiment, a pharmaceutical composition is provided comprising a pancreatin micropellet with the enteric coating being designed to deliver pancreatin to the upper portion of the intestine of a mammal for release.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: March 8, 2022
    Assignee: ABBVIE PHARMACEUTICALS GMBH
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Guido Ruesing
  • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
    Publication number: 20210353722
    Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
    Type: Application
    Filed: June 23, 2021
    Publication date: November 18, 2021
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Andreas Koerner
  • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
    Publication number: 20210060142
    Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
    Type: Application
    Filed: November 12, 2020
    Publication date: March 4, 2021
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Andreas Koerner
  • Processes for the Manufacture and Use of Pancreatin
    Publication number: 20200299669
    Abstract: A process for the manufacture and use of pancreatin in which the concentration of one or more biological contaminants is reduced, such as viruses and/or bacteria, through heating the pancreatin at a temperature of at least 85° C. for a period of less than about 48 hours.
    Type: Application
    Filed: June 4, 2020
    Publication date: September 24, 2020
    Inventors: Heinz Blume, Martin Frink, Claus-Juergen Koelln, Michael Rust
  • Processes for the manufacture and use of pancreatin
    Patent number: 10704037
    Abstract: A process for the manufacture and use of pancreatin in which the concentration of one or more biological contaminants is reduced, such as viruses and/or bacteria, through heating the pancreatin at a temperature of at least 85° C. for a period of less than about 48 hours.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: July 7, 2020
    Inventors: Heinz Blume, Martin Frink, Claus-Juergen Koelln, Michael Rust
  • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
    Publication number: 20190247473
    Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 15, 2019
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Andreas Koerner
  • Processes for the Manufacture and Use of Pancreatin
    Publication number: 20170073660
    Abstract: A process for the manufacture and use of pancreatin in which the concentration of one or more biological contaminants is reduced, such as viruses and/or bacteria, through heating the pancreatin at a temperature of at least 85° C. for a period of less than about 48 hours.
    Type: Application
    Filed: July 20, 2016
    Publication date: March 16, 2017
    Applicant: Abbott Products GmbH
    Inventors: Heinz Blume, Martin Frink, Claus-Juergen Koelln, Michael Rust
  • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
    Publication number: 20160263201
    Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
    Type: Application
    Filed: May 24, 2016
    Publication date: September 15, 2016
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Andreas Koerner
  • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
    Publication number: 20160095906
    Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
    Type: Application
    Filed: October 13, 2015
    Publication date: April 7, 2016
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Andreas Koerner
  • Delayed release pancreatin compositions
    Patent number: 9198871
    Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: December 1, 2015
    Assignee: Abbott Products GmbH
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Andreas Koerner
  • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
    Publication number: 20140065232
    Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
    Type: Application
    Filed: November 7, 2013
    Publication date: March 6, 2014
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Andreas Koerner
  • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
    Publication number: 20070148153
    Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
    Type: Application
    Filed: August 15, 2006
    Publication date: June 28, 2007
    Inventors: George SHLIEOUT, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Andreas Koerner
  • PROCESS FOR THE MANUFACTURE AND USE OF PANCREATIN MICROPELLET CORES
    Publication number: 20070148152
    Abstract: A process for manufacturing and using pancreatin micropellet cores and pancreatin micropellets which are substantially free of synthetic oils. In one embodiment, a pharmaceutical composition is provided comprising a pancreatin micropellet with the enteric coating being designed to deliver pancreatin to the upper portion of the intestine of a mammal for release.
    Type: Application
    Filed: August 15, 2006
    Publication date: June 28, 2007
    Inventors: George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Guido Ruesing
  • PROCESSES FOR THE MANUFACTURE AND USE OF PANCREATIN
    Publication number: 20070148151
    Abstract: A process for the manufacture and use of pancreatin in which the concentration of one or more biological contaminants is reduced, such as viruses and/or bacteria, through heating the pancreatin at a temperature of at least 85° C. for a period of less than about 48 hours.
    Type: Application
    Filed: July 27, 2006
    Publication date: June 28, 2007
    Inventors: Martin Frink, Claus-Juergen Koelln, Heinz Blume, Michael Rust